US2011002874A1PendingUtilityA1
Polymer Network Compositions and Associated Methods
Est. expiryApr 28, 2025(expired)· nominal 20-yr term from priority
C08F 265/00C08F 265/10C08F 251/00C08L 51/003C08F 265/04A61K 47/6903A61K 47/60A61K 47/58C08F 283/00C08L 51/02
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Biomimetic polymer networks comprising a heteropolymer network having a cavity, the cavity having a selective affinity for a moiety, methods for making biomimetic polymer networks, and methods for using biomimetic polymer networks.
Claims
exact text as granted — not AI-modified1 . A biomimetic polymer network comprising a heteropolymer network having a cavity, the cavity having a selective affinity for a moiety.
2 . The biomimetic polymer network of claim 1 wherein the cavity and moiety interact through noncovalent binding.
3 . The biomimetic polymer network of claim 1 further comprising the moiety.
4 . The biomimetic polymer network of claim 1 further comprising the moiety, wherein the moiety is conjugated to a molecule.
5 . The biomimetic polymer network of claim 1 further comprising the moiety, wherein the moiety is conjugated to a molecule that is a therapeutic agent.
6 . The biomimetic polymer network of claim 1 further comprising the moiety, wherein the moiety is chosen from one or more of a sugar, a lipid, a carbohydrate, a peptide, and a functional group.
7 . A biomimetic polymer network formed by a process comprising polymerizing a mixture comprising monomers and crosslinkers in the presence of a moiety for which a molecular imprint is to be produced, thereby forming a matrix comprising an imprint of the molecule, and separating the moiety from the matrix.
8 . The biomimetic polymer network of claim 7 wherein the mixture comprises a prepolymerization complex, the prepolymerization complex comprising a moiety for which a molecular imprint is to be produced.
9 . The biomimetic polymer network of claim 7 wherein the moiety is chosen from one or more of, a lipid, a carbohydrate, a peptide, and a functional group.
10 . The biomimetic polymer network of claim 7 wherein the moiety is conjugated to a molecule that is a therapeutic agent.
11 . A method for forming a biomimetic polymer network comprising
polymerizing a mixture comprising monomers and crosslinkers in the presence of a moiety for which a molecular imprint is to be produced, thereby forming a matrix comprising an imprint of the molecule, and separating the moiety from the matrix.
12 . The method of claim 11 wherein the mixture comprises a prepolymerization complex, the prepolymerization complex comprising a moiety for which a molecular imprint is to be produced.
13 . The method of claim 11 wherein the moiety is chosen from one or more of a lipid, a carbohydrate, a peptide, and a functional group.
14 . The method of claim 11 wherein the moiety is conjugated to a molecule that is a therapeutic agent.
15 . A method for delivering a molecule comprising: providing a biomimetic polymer network comprising a heteropolymer network having a cavity, the cavity having a selective affinity for a moiety;
loading the biomimetic polymer network with a molecule by allowing a moiety present on the molecule to interact with the cavity; delivering the biomimetic polymer network to a desired location; and providing conditions that reduce the affinity of the cavity for the moiety a sufficient amount to release the molecule.
16 . The method of claim 15 wherein the moiety is conjugated to a molecule.
17 . The method of claim 15 wherein the moiety is conjugated to a molecule that is a therapeutic agent.
18 . The method of claim 15 wherein the moiety is chosen from one or more of, a lipid, a carbohydrate, a peptide, and a functional group.
19 . The method of claim 17 wherein the therapeutic agent is toxic.
20 . The method of claim 17 wherein the therapeutic agent comprises a small molecule.Join the waitlist — get patent alerts
Track US2011002874A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.